Sr. Director and US Therapy Area Head, Specialty Medicines

The external environmental demands for robust evidence of the value of our assets continues to increase, with external stakeholders and decision makers increasingly demanding demonstration of the comparative clinical, economic, and humanistic benefits of our medicine at the time of launch, and thereafter. At the same time, the GSK organization is launching or soon to launch many new medicines, all of which will require significant leadership and evidence delivery from health outcomes to ensure successful translation of these reimbursement/payer requirements into our clinical development programs and delivery of the additional evidence that demonstrates value. 

To meet these needs, The Therapy Area (TA) Head, US, is responsible for the design and implementation of evidence generation activities in support of a GSK Therapy Area (TA) for the United States (US) business. It includes health outcomes leadership and execution for launch, post launch and life cycle management programs.  The TA Head leads a team of RWE-HO scientists and may also serve as an Asset Lead in their own right. The TA Head is responsible for the generation of compelling value evidence for decision-makers and to support reimbursement dossiers and market access in the US. Their remit includes both pipelines and marketed assets.

This role will provide YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following…

Evidence Generation

• Lead and/or provide oversight for the development, management, design, implementation and delivery of US health outcome strategy and tactical plans for pipeline and marketed assets in a specific TA.

• To maintain an awareness of the significant developments in US health care environment and how these developments impact US evidence generation

• For pipeline assets, provide input to global RWE-HO and integrated asset plans, through appropriate forums, to ensure US needs are accommodated.

• Ensure TA aligned RWE-HO projects meet quality standards and are tracked, monitored, reported and disclosed according to all relevant policies and procedures.

• Ensure TA aligned RWE-HO projects are delivered to time and on budget.

Evidence Communication

• Develop scientific communications i.e., presentations, manuscripts, registry summaries and data dissemination plans that include promotional pieces to communicate/disseminate health outcomes data with external stakeholders. 

• Leverage health outcomes data with Payers and Providers, through appropriate/approved mechanisms.

• Train field staff on health outcomes data and promotional materials, as appropriate for organizational role.

Line Management

• Lead, manage, recruit and develop RWE-HO scientists

• Manage RWE-HO resource planning, allocation among scientists within team to support projects based on the needs of your portfolio.

• Drive best practice sharing across the team in support of strategy development and methodology.

Stakeholder management

• Develop and maintain excellent working relations with key stakeholders in the US LOC and Global RWE-HO teams, in order to ensure strategic alignment and optimal cross-functional collaboration and communication.

• Ensure key stakeholders including TA aligned business leaders are regularly updated on RWE-HO plans through period reporting.

• Develop and maintain excellent working relations with external health outcomes experts/thought leaders, to ensure appropriate methods in health economics and quality of life research are applied, in accordance with GSK policies.

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• Master’s degree in a relevant discipline i.e., health economics and/or outcomes research; health care policy; health services research; epidemiology etc.

• 7+ years US pharmaceutical industry experience, preferably in a multi-national company

• Experience with Health Outcomes research and application.

• Experience with Pharma R&D, especially clinical trial planning and execution.

• US healthcare environment acumen.

• Experience with reimbursement and market access solutions for product development and post-launch plans.

• Experience with application of RWE-HO research at the product and therapy area levels

• Understanding of how health economic, health outcomes, comparative effectiveness research